Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $487K | ﹤0.01% |
+9,100
| New | +$482K |
|
|
TBCH
2902
Turtle Beach Corp
TBCH
$243M
| $487K | ﹤0.01% |
+48,600
| New | +$412K |
|
|
LSXMK
2903
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $487K | ﹤0.01% |
+22,463
| New | +$592K |
|
2904
iShares MSCI Australia ETF
EWA
$1.39B
| $486K | ﹤0.01% |
+21,200
| New | +$496K |
|
2905
MoonLake Immunotherapeutics
MLTX
$1.57B
| $486K | ﹤0.01% |
22,700
+11,091
| +96% | +$186K |
|
2906
Vishay Intertechnology
VSH
$5.25B
| $486K | ﹤0.01% |
21,500
-101,525
| -83% | -$2.23M |
|
2907
VSE Corp
VSEC
$5.45B
| $485K | ﹤0.01% |
+10,800
| New | +$547K |
|
2908
ACNB Corp
ACNB
$656M
| $484K | ﹤0.01% |
14,856
+200
| +1% | +$7.29K |
|
2909
Sphere Entertainment
SPHR
$5.14B
| $484K | ﹤0.01% |
8,200
-30,400
| -79% | -$1.64M |
|
|
HLGN
2910
DELISTED
Heliogen, Inc.
HLGN
| $484K | ﹤0.01% |
57,583
+15,103
| +36% | +$229K |
|
2911
Gold Royalty Corp
GROY
$600M
| $481K | ﹤0.01% |
222,514
+39,594
| +22% | +$90.9K |
|
2912
PROG Holdings
PRG
$1.75B
| $480K | ﹤0.01% |
20,184
-47,000
| -70% | -$1.06M |
|
|
CLSD
2913
DELISTED
Clearside Biomedical
CLSD
| $478K | ﹤0.01% |
30,626
-8,533
| -22% | -$166K |
|
|
GAN
2914
DELISTED
GAN Ltd
GAN
| $477K | ﹤0.01% |
369,574
-35,836
| -9% | -$65.2K |
|
2915
V2X
VVX
$2.83B
| $477K | ﹤0.01% |
12,003
+5,236
| +77% | +$224K |
|
2916
Greene County Bancorp
GCBC
$570M
| $471K | ﹤0.01% |
20,782
+8,382
| +68% | +$215K |
|
2917
Applied Optoelectronics
AAOI
$7.57B
| $469K | ﹤0.01% |
212,000
+17,800
| +9% | +$43.6K |
|
2918
Dimensional International Core Equity 2 ETF
DFIC
$14.8B
| $469K | ﹤0.01% |
19,500
-6,800
| -26% | -$162K |
|
2919
Citius Pharmaceuticals
CTXR
$15.6M
| $467K | ﹤0.01% |
15,971
-396
| -2% | -$11.4K |
|
2920
Cellebrite
CLBT
$3.68B
| $466K | ﹤0.01% |
76,600
+63,300
| +476% | +$343K |
|
2921
Electro-Sensors
ELSE
$27.3M
| $464K | ﹤0.01% |
99,300
-5,300
| -5% | -$23.9K |
|
2922
Kingstone Companies
KINS
$289M
| $464K | ﹤0.01% |
346,989
-500
| -0.1% | -$735 |
|
2923
CVRx
CVRX
$137M
| $463K | ﹤0.01% |
49,700
+16,400
| +49% | +$217K |
|
2924
Banner Corp
BANR
$2.39B
| $462K | ﹤0.01% |
8,500
-42,199
| -83% | -$2.58M |
|
2925
DocGo
DCGO
$64.3M
| $461K | ﹤0.01% |
53,309
-267,091
| -83% | -$2.36M |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.